Skip to main content
. 2008 Aug 9;19(12):2079–2083. doi: 10.1093/annonc/mdn431

Table 2.

Dose-limiting toxicity (DLT) and best response

Bortezomib (mg/m2/dose) Cyclophosphamide (mg/m2/dose) Doxorubicin (mg/m2/dose) Total no. of patients DLT No. of cycles Best response
1.0 750 50 7 Grade 4 neutropenia with fever 34 5 CRs, 1 SD, 1 PD
1.3 750 50 3 None 13 2 SDs, 1 CR
1.6 750 50 3 None 8 1 CR, 1 CRu, 1 PD

CR, complete remission; SD, stable disease; PD, progressive disease; CRu, complete remission, undetermined.